PRMT3 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.20485868346532E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.43159999965725E-07 |
Normal-vs-Stage2 |
3.584900E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
9.477000E-03 |
Stage1-vs-Stage2 |
1.830610E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
9.854800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
3.201600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.03969968587603E-10 |
Normal-vs-AfricanAmerican |
1.047620E-01 |
Normal-vs-Asian |
2.042400E-02 |
Caucasian-vs-AfricanAmerican |
9.381600E-02 |
Caucasian-vs-Asian |
9.371200E-01 |
AfricanAmerican-vs-Asian |
8.071700E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.6299599999936E-05 |
Normal-vs-Female |
1.721500000329E-07 |
Male-vs-Female |
8.291400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.478400E-03 |
Normal-vs-Extreme_Weight |
6.57479999999211E-07 |
Normal-vs-Obese |
3.299600E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
1.059380E-01 |
Normal_Weight-vs-Obese |
1.329800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.652200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.83710047174657E-10 |
Normal-vs-Age(41-60Yrs) |
6.22390000000195E-05 |
Normal-vs-Age(61-80Yrs) |
1.96910000005435E-06 |
Normal-vs-Age(81-100Yrs) |
1.421410E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.362400E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.019250E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.938600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.299600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.117200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.439600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.478820E-01 |
Normal-vs-Grade 3 |
2.670200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.563800E-01 |
Grade 2-vs-Grade 4 |
1.478820E-01 |
Grade 3-vs-Grade 4 |
2.670200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.76419995173904E-09 |
Normal-vs-N1 |
4.319100E-03 |
N0-vs-N1 |
9.358400E-02 |
|
|